Yield Hunters Are Swarming This 6.3%-Dividend Stock—And Big-League Hedge Funds are Quietly Buying the Dip

Recent 13F filings show big-league hedge funds increasing positions in Pfizer (PFE), indicating renewed “smart money” interest. The article does not provide the size of buys, timing, or changes to guidance/earnings. Overall, the signal is mildly supportive via sentiment, but with limited immediate fundamentals information.

Analysis

Recent 13F filings show big-league hedge funds increasing positions in Pfizer (PFE), indicating renewed “smart money” interest. The article does not provide the size of buys, timing, or changes to guidance/earnings. Overall, the signal is mildly supportive via sentiment, but with limited immediate fundamentals information.